Hanoi (VNA) – The Ministry of
Health (MoH) has urged Nanogen Biopharmaceutical Co. Ltd. to complete
procedures to promptly carry out on humans in November.
Human trials of “made-in-Vietnam” COVID-19
vaccine developed by Nanogen Biopharmaceutical might be implemented soon following
the completion of paperwork, said Nguyen Ngo Quang, Vice Director of the MoH’s Administration
of Science, Technology and Training on November 3.
The first phase expects to conduct tests on
a group of 20 volunteers, while the second phase will involve 600 people and
the third phase, 10,000 people.
If successful, the vaccine, which is being
tested on animals, will be the first one in Vietnam to have .
is capable of producing about 30 million doses of
vaccine annually, meeting domestic demands.
The vaccine developed by Nanogen Biopharmaceutical
is now one of the two most potential vaccines in Vietnam.
In late October, a vaccine developed by the
Vaccine and Biological Production Company (Vabiotech) under the MoH was tested
on monkeys. The results of the testing will be a foundation for the next stage
and proposal to test the vaccine on people.
In June 2020, Vabiotech tested the vaccine
on mice./.
Source: VietnamPlus
